John M. Evans - Jun 25, 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Chief Executive Officer, Director
Signature
By: Christine Bellon, as Attorney-in-Fact
Stock symbol
BEAM
Transactions as of
Jun 25, 2021
Transactions value $
$0
Form type
4
Date filed
6/30/2021, 06:00 PM
Previous filing
Jun 16, 2021
Next filing
Jul 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Small acquisition under Rule 16a-6 $0 +32 +0% $0.00 1.02M Jun 25, 2021 Direct F1
transaction BEAM Common Stock Small acquisition under Rule 16a-6 $0 +32 +0% $0.00 1.02M Jun 28, 2021 Direct F1
transaction BEAM Common Stock Other $0 +32 +0% $0.00 1.02M Jun 29, 2021 Direct F1
holding BEAM Common Stock 223K Jun 25, 2021 By John M. Evans, III 2018 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of BEAM common stock held by ARCH Venture Fund IX, L.P. to its partners for no consideration.